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Background/aim: Coronavirus 2019 disease (Covid-19) was first seen in December 2019 and afterwards it became pandemic.
Several systemic involvements have been reported in Covid-19 patients. In this study, it was aimed to investigate the cerebrovascular
hemodynamics in patients with Covid-19.
Materials and methods: The sample of this study included 20 patients hospitalized in our clinic diagnosed with Covid-19 via PCR
modality and 20 healthy volunteers of similar age and sex. Bilateral middle cerebral arteries were investigated with transcranial Doppler
ultrasonography. Basal cerebral blood flow velocities and vasomotor reactivity rates were determined and statistically compared.
Results: When patient and control groups were compared, the mean blood flow velocity was found to be higher in Covid-19 patients
than in the healthy volunteers and it was statistically significant (P = 0.00). The mean vasomotor reactivity rates values were found to be
lower in the Covid-19 group than the healthy group and was also statistically significant (P = 0.00).
Conclusion: An increase in basal cerebral blood velocity and a decrease in vasomotor reactivity rates in patients with Covid-19 can be
considered as an indicator of dysfunction of cerebral hemodynamics in the central nervous system and this can be evaluated as a result
of endothelial dysfunction.
Key words: Covid-19, SARS-Cov-2, blood flow velocity, vasomotor reactivity

1. Introduction
It came to attention that the number of pneumonia cases
increased in December 2019 in Wuhan, China. As a result
of the studies conducted a new virus belonging to the
coronavirus family has been isolated as the cause of this
disease, which has a high mortality rate despite influenzalike symptoms. Firstly, this virus was named 2019-nCoV,
but in the following days it was identified as SARS-CoV-2.
The disease that developed from this virus was called
COVID-191.
Coronaviruses (CoVs) such as influenza, are commonly
seen in society. People affected with coronaviruses may
be asymptomatic or have symptoms ranging from mild
influenza-like symptoms to severe respiratory distress.
Other viral outbreaks, such as Middle East Respiratory
Syndrome (MERS) and Severe Acute Respiratory
Syndrome (SARS) which both belong to the CoV family
have recently occurred with varying clinical status [1–4].
Covid-19 spread rapidly all over the world and
was declared as a pandemic by the World Health

Organization (WHO) in March 2020. Advanced age,
immunosuppression, or concomitant systemic diseases
(such as hypertension, diabetes mellitus, cardiovascular
diseases, malignancy etc.) were determined as the most
important factors on mortality [5,6]. Symptoms occur
approximately 5 days after viral exposure (incubation
period) [7]. Fever, cough, and fatigue are seen in many
patients while neurological symptoms such as headache,
epileptic seizure, stroke, odor-taste disturbance,
neuralgias, and changes in consciousness have also been
reported [2,8,9]. Causes of neurological manifestations are
not still fully understood.
Besides the respiratory symptoms, many systemic
(neurologic,
dermatologic,
and
gastrointestinal)
manifestations may be seen in humans and these symptoms
are sometimes the first and unique clues leading to the
diagnosis of Covid-19s [10–13]. Endothelial dysfunction
may be determined as the reason of these manifestations.
Transcranial Doppler (TCD) is a noninvasive
ultrasonography modality that allows dynamic monitoring

1
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of cerebral blood flow velocity and its changes [14–16].
With this modality, cerebral blood flow cannot be directly
demonstrated, but its velocity can be monitored. In this
study, the aim was to investigate the cerebrovascular
hemodynamics in patients with Covid-19 via TCD and to
evaluate the vasomotor reactivity (VMR) capacity with the
breath-holding index (BHI).
2. Materials and methods
The sample of this study included 20 patients hospitalized
in our clinic diagnosed with Covid-19 via PCR modality
and 20 healthy volunteers of similar age and sex. Patients
needing intubation, who had history of performed cranial
surgery, who had unsuitable temporal window for TCD,
and pregnant patients were excluded from the study.
Demographic data such as age and sex were recorded. TCD
measurements of patients were evaluated immediately
after hospitalization. All participants were informed about
the examination and their written consent was obtained
before the study.
DWL Multi-Dop T tool and QL software 2.8 were
used for TCD examination. The middle cerebral arteries
were insonated at an average depth of 45–60 mm through
temporal bone window using 2 Mhz probes. After the
vascular structures were determined bilaterally, two probes
were fixed to the head with a frame. Patients were at rest
for 10 min in a quiet room before the measurements were
obtained. In order to evaluate mean basal cerebral blood
velocity a 5-min record was obtained. The mean of blood
flow velocity in these 5-min records was calculated and the
average of these recordings was determined as the basal
blood flow velocity. Afterwards patients were informed,

and they were requested to hold their breath for 30 s to
calculate the BHI. In the BHI study, the maximum point
of blood flow velocity increases with the first breath taken
after 30 s of breath-holding, and this was determined as
the maximum speed. Cerebral blood flow velocity and
BHI were calculated as shown in Figures 1 and 2.
For statistical analysis, SPSS 26.0 was used. Descriptive
statistics were used for demographic data. Qualitative
variables were indicated with frequency, and percentage
and numerical variables were summarized by mean ±
standard deviation. The Shapiro–Wilk test was used for
determining normality. The Shapiro–Wilk Test is more
appropriate for small sample sizes. For this reason, the
Shapiro–Wilk test was used as a numerical means of
assessing normality. In comparisons between groups Chisquare and Mann–Whitney U tests were used, and P < 0.05
is accepted as statistically significant.
3. Results
The study was conducted on 20 patients (13 male +
7 female) with diagnosed Covid-19 and 20 healthy
volunteers (14 male + 6 female). The lowest age was 21
and the highest age was 81 in the patient group. The mean
age of the patient group was 50.15 ± 19.07. In the control
group, the lowest age was 21 and the highest age was 79.
The mean age of the patient group was 47.90 ± 18.80. There
was no significant difference between the two groups with
respect to age and sex (P > 0.05).
In the right and left middle cerebral arteries (MCAs),
there were no significant differences between the patient
and control groups in terms of both basal blood flow
velocity values and VMR (P = 0.61, P = 0.89 vs. P = 0.24,

Figure 1. Cerebral blood flow changes during breath holding (Vrest: mean blood
flow velocity in rest, Vmax: maximum blood flow velocity). Blood flow velocity is
measured using TCD from the right (green) and left (red) middle cerebral arteries
bilaterally.
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Figure 2. Calculation of breath-holding index (Vrest: mean blood
flow velocity in rest, Vmax: maximum blood flow velocity).

P = 0.40, respectively) (Table). The mean blood flow
velocity was found to be higher in the patient group than
the control group and it was statistically significant (P =
0.01). The mean VMR values were found to be lower in the
patient group than the control group and it was statistically
significant (P = 0.01).
4. Discussion
In this study, VMR evaluated with basal blood flow and
BHI obtained from bilateral MCAs via TCD in patients
with Covid-19 and healthy volunteers was investigated.
According to the results, basal blood flow velocity rates of
patients with Covid-19 were found to be higher than the
healthy group. In contrast to the basal blood flow velocity,
VMR values of patients with Covid-19 were found to be
lower than the healthy group.
Cerebral autoregulation is a homeostatic process that
maintains cerebral blood flow at regular intervals, despite
fluctuations in cerebral perfusion pressure [17]. Changes
in the vascular tonus have a key role in ensuring cerebral
hemodynamics. Cerebral blood flow is particularly
sensitive to blood carbon dioxide exchange, but in some
cases where the level of carbon dioxide remains constant,
it is known that cerebral blood flow can be regulated by
adjusting the heart rate or peripheral circulation [18].
The mechanisms of cerebral autoregulation remain
poorly
understood,
especially
in
humans.

Generally,
three
different
mechanisms,
metabolic, myogenic, and neurogenic are thought to
contribute to the process of cerebral autoregulation.
These mechanisms affect the cerebral blood flow and this
provides the regulation [19]. VMR provides information
about the capacity of the cerebral autoregulation and can
be evaluated with several modalities, such as the BHI
method.
TCD is a noninvasive, reproducible, bedside
practicable diagnostic tool that can demonstrate the blood
flow velocity and direction in major intracranial arteries.
Cerebral arterial autoregulation is constituted with changes
in the diameters of small arteries. There are no significant
changes in the diameters of these vessels during normal
pressure changes, or the constituted changes are negligible.
Therefore, relative blood flow alterations resulting from
diameter changes in small vessels can be evaluated as an
autoregulation response [19,20].
Several studies have been made regarding cerebral
autoregulation, in particular in patients with migraine,
and changes in VMR and basal blood flow velocity
were observed in many of these studies [21,22]. In the
Rotterdam study, which was conducted by Portegies et
al., decreased VMR results were found to be related to
mortality. Authors reported that stroke was independent
of this relationship and the decreased VMR values were
based on impairment of the vascular system [23]. Similarly
to this study, Ju et al., also reported that decreased VMR
is an important prognostic factor for stroke [24]. In one
study carried out by Mamontov et al., the low neurogenic
reactivity against increased peripheral vascular tonus was
found to be the worst prognostic factor in hypertensive
patients [25].
Hypertension is one of the most important factors
of poor prognosis in patients with Covid-19 [5,6]. In
addition, many different studies have shown that patients
with Covid-19 tend to thrombosis, and also stroke cases
have been reported in these studies [26–32]. In particular
in cases related to thrombus, an underlying endothelial

Table. Comparison between right and left MCAs in the patient and control groups in terms of BFL and VMR.
Covid-19 (mean ± sd)
LMCA BFL

P value

RMCA BFL

61.32 ± 3.58

60.77 ± 4.82

LMCA VMR

RMCA VMR

1.18 ± 0.03

1.17 ± 0.02

0.61
0.89

Healthy (mean ± sd)
LMCA BFL

RMCA BFL

56.94 ± 4.73

55.89 ± 5.45

LMCA VMR

RMCA VMR

1.38 ± 0.01

1.36 ± 0.01

P value
0.24
0.40

LMCA BFL: left middle cerebral artery blood flow velocity, RMCA BFL: right middle cerebral artery blood
flow velocity, LMCA VMR: left middle cerebral artery vasomotor reactivity, RMCA VMR: right middle
cerebral artery vasomotor reactivity.
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dysfunction has been accused. Varga et al. have
histopathologically shown that the SARS-CoV-2 virus
caused endothelial damage [33]. In addition to endothelial
physical barrier function, it also has paracrine, endocrine,
and autocrine implications. In this way, it affects the
vascular tonus and provides the vascular homeostasis [34].
Endothelial damage disrupts the balance in the vascular
tonus and it causes the ischemia, edema, and procoagulant
state in the organ in which it is located [35].
As a result of this study, an increase in cerebral basal
blood velocity and a decrease in VMR was found in patients
with Covid-19. It is thought that this can be evaluated as a

result of endothelial dysfunction in the vascular structures
of central nervous system.
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